Fatty Liver Disease Study Using Wearable Tracking
Part of Hormones & metabolism clinical trials.
This research studies fatty liver disease linked to metabolic problems like diabetes and obesity. You'll wear a fitness tracker and have liver imaging to help doctors understand the disease and find new treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have metabolic problems like type 2 diabetes, high blood pressure, high cholesterol, or central obesity (BMI ≥25)
- Liver imaging shows signs of fat buildup in your liver (liver stiffness ≥8, CAP ≥248, or MRI showing ≥5% fat)
- You have not lost more than 10% of your body weight in the past 6 months through diet alone
- You drink safely: less than 30g daily if male, less than 20g daily if female (roughly 2 drinks or fewer per day)
- You own a compatible smartphone (Android 7.0+ or iOS 14.0+) to use the study's fitness tracker app
- You do not have cirrhosis, decompensated liver disease, HIV, autoimmune hepatitis, or other liver diseases
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
This study tests a new device called LiverScope® that scans your liver to detect fatty liver disease (MASLD). The scan uses special imaging technology and may help doctors diagnose liver disease more quickly and accurately.
This study is testing whether advanced imaging and other non-invasive methods can properly identify people with significant liver scarring due to metabolic liver disease or alcohol-related liver disease. It may help find better ways to track liver health without repeated needle biopsies.
This study checks how fatty liver disease (a condition where fat builds up in the liver) affects the heart. If you have this liver condition and are between 18 and 65, you may help doctors understand the link between liver health and heart function.
This study tests if restricting eating to daytime hours for 12 weeks can reduce liver fat in people with obesity. It aims to help those with fatty liver disease improve their health without medication.
This trial tests a digital diet and exercise program to help reduce liver scarring in people with fatty liver disease. You'll use an app or online tool to follow healthy eating and activity routines, which may slow or reverse liver damage.
Hear when a new MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.